Search - tctmd.com

Displaying 1 - 20 of 174

Sort: Relevancy | Date

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

October 26, 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

News Daily News

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

July 14, 2025

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

News Daily News

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Yael L. Maxwell

March 10, 2025

ACC/AHA Release New Comprehensive ACS Guidelines

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

February 27, 2025

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

Surgeons Formalize Support for ESC’s Stance on Revascularization in CCS

News Daily News

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Michael O'Riordan

January 20, 2025

TCT 172: Usefulness of FFR-CT to Exclude Hemodynamically Significant Lesions in High-Risk NSTE-ACS

Presentation TCT 2024

TCT 172: Usefulness of FFR-CT to Exclude Hemodynamically Significant Lesions in High-Risk NSTE-ACS

Presenter: Georgios Tzimas

October 28, 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

May 10, 2024

State-of-the-Art in NSTE-ACS: Management Strategies

Presentation Fellows 2024

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Binita Shah

April 12, 2024

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

October 25, 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

News Conference News ESC 2023

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

August 22, 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

May 30, 2023

Many ACS Patients With Occlusions Are Falling Through the Cracks

News Conference News EuroPCR 2023

Many ACS Patients With Occlusions Are Falling Through the Cracks

May 19, 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presentation Fellows 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 11, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.